Shivalik Rasayan Limited (SHIVALIK) fundamentals
Shivalik Rasayan Limited is a listed company in Fertilizers & Agrochemicals, part of the Chemicals sector, listed on the NSE as SHIVALIK (ISIN INE788J01021). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Shivalik Rasayan Limited does
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Valuation and market data
| Last close | ₹364.00 |
|---|---|
| Market capitalisation | ₹701 crore |
| Enterprise value | ₹693 crore |
| P/E (TTM) | 0.00 |
| Price to book | 1.31 |
| Price to sales (TTM) | 1.85 |
| Book value per share | ₹278.36 |
| Dividend yield | 13.74% |
| Sector | Chemicals |
| Industry | Fertilizers & Agrochemicals |
| Listed since | Thu Dec 09 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹372 crore | ₹21 crore | ₹18 crore | 0.00 |
| Mar 2025 | ₹320 crore | ₹23 crore | ₹20 crore | 10.60 |
| Mar 2024 | ₹277 crore | ₹23 crore | ₹18 crore | 8.35 |
| Mar 2023 | ₹239 crore | ₹32 crore | ₹30 crore | 14.32 |
| Mar 2022 | ₹218 crore | ₹37 crore | ₹34 crore | 18.12 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 47.4% |
|---|---|
| Foreign institutions (FII) | 1.2% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 51.4% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.